TW222630B - - Google Patents
Info
- Publication number
- TW222630B TW222630B TW081107550A TW81107550A TW222630B TW 222630 B TW222630 B TW 222630B TW 081107550 A TW081107550 A TW 081107550A TW 81107550 A TW81107550 A TW 81107550A TW 222630 B TW222630 B TW 222630B
- Authority
- TW
- Taiwan
- Prior art keywords
- carbon atoms
- alkyl
- halogen
- atomic number
- hydrogen
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4131584A DE4131584A1 (de) | 1991-09-23 | 1991-09-23 | Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW222630B true TW222630B (OSRAM) | 1994-04-21 |
Family
ID=6441240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081107550A TW222630B (OSRAM) | 1991-09-23 | 1992-09-24 |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0534904B1 (OSRAM) |
| JP (1) | JP2568356B2 (OSRAM) |
| KR (1) | KR100254085B1 (OSRAM) |
| AT (1) | ATE144509T1 (OSRAM) |
| AU (1) | AU650569B2 (OSRAM) |
| CA (1) | CA2078700C (OSRAM) |
| CZ (1) | CZ281675B6 (OSRAM) |
| DE (2) | DE4131584A1 (OSRAM) |
| DK (1) | DK0534904T3 (OSRAM) |
| ES (1) | ES2092666T3 (OSRAM) |
| FI (1) | FI103887B (OSRAM) |
| GR (1) | GR3021444T3 (OSRAM) |
| HU (2) | HUT61993A (OSRAM) |
| IL (1) | IL103229A (OSRAM) |
| MX (1) | MX9205365A (OSRAM) |
| MY (1) | MY110450A (OSRAM) |
| NO (1) | NO301162B1 (OSRAM) |
| NZ (1) | NZ244420A (OSRAM) |
| RO (1) | RO109337B1 (OSRAM) |
| RU (1) | RU2058312C1 (OSRAM) |
| SG (1) | SG43079A1 (OSRAM) |
| SK (1) | SK289692A3 (OSRAM) |
| TW (1) | TW222630B (OSRAM) |
| ZA (1) | ZA927279B (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10165349A (ja) * | 1996-12-06 | 1998-06-23 | Matsushita Electric Ind Co Ltd | 食器洗浄機 |
| DE10000161A1 (de) * | 2000-01-06 | 2001-07-19 | Boehringer Ingelheim Pharma | Verfahren zur Identifikation eines Proteaseinhibitors |
| GB0009037D0 (en) * | 2000-04-13 | 2000-05-31 | Novartis Ag | Organic compounds |
| EP1718291A1 (en) * | 2004-02-19 | 2006-11-08 | Novartis AG | Use of cholinesterase inhibitors for treating vascular depression |
| AU2006275824B2 (en) | 2005-07-29 | 2010-12-16 | Vanda Pharmaceuticals, Inc. | Method of improving wakefulness |
| CA2642275A1 (en) * | 2006-02-13 | 2007-08-23 | Vanda Pharmaceuticals, Inc. | Stable dosage formulations of imidazolylalkyl-pyridines |
| WO2009097416A1 (en) * | 2008-01-29 | 2009-08-06 | Vanda Pharmaceuticals, Inc. | Imidazolylalkyl- pyridines as dbh inhibitors |
| JP6265583B2 (ja) | 2008-10-17 | 2018-01-24 | ウィスコンシン アルムニ リサーチ ファンデイション | 生理活性アルファベータペプチドを作製する方法 |
| US9394290B2 (en) * | 2010-10-21 | 2016-07-19 | Universitaet Des Saarlandes Campus Saarbruecken | Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases |
| WO2018217631A1 (en) * | 2017-05-22 | 2018-11-29 | Torrey Pines Institute For Molecular Studies | Compositions, methods of use, and methods of treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2862340D1 (en) * | 1978-02-01 | 1983-11-24 | Wellcome Found | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
| GB2028317B (en) * | 1978-08-15 | 1982-11-10 | Pfizer Ltd | 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors |
| US4634711A (en) * | 1985-08-02 | 1987-01-06 | Smithkline Beckman Corporation | Pyridylalkyl imidazole-2-thiols |
| DE3811574A1 (de) * | 1988-03-31 | 1989-10-19 | Schering Ag | N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
-
1991
- 1991-09-23 DE DE4131584A patent/DE4131584A1/de not_active Withdrawn
-
1992
- 1992-09-09 HU HU9202886A patent/HUT61993A/hu unknown
- 1992-09-18 MY MYPI92001673A patent/MY110450A/en unknown
- 1992-09-21 DK DK92810719.2T patent/DK0534904T3/da active
- 1992-09-21 ES ES92810719T patent/ES2092666T3/es not_active Expired - Lifetime
- 1992-09-21 SK SK2896-92A patent/SK289692A3/sk not_active IP Right Cessation
- 1992-09-21 FI FI924233A patent/FI103887B/fi not_active IP Right Cessation
- 1992-09-21 NO NO923653A patent/NO301162B1/no not_active IP Right Cessation
- 1992-09-21 AT AT92810719T patent/ATE144509T1/de active
- 1992-09-21 CA CA002078700A patent/CA2078700C/en not_active Expired - Fee Related
- 1992-09-21 SG SG1996003366A patent/SG43079A1/en unknown
- 1992-09-21 EP EP92810719A patent/EP0534904B1/de not_active Expired - Lifetime
- 1992-09-21 AU AU25226/92A patent/AU650569B2/en not_active Ceased
- 1992-09-21 DE DE59207425T patent/DE59207425D1/de not_active Expired - Lifetime
- 1992-09-21 CZ CS922896A patent/CZ281675B6/cs not_active IP Right Cessation
- 1992-09-21 IL IL10322992A patent/IL103229A/en not_active IP Right Cessation
- 1992-09-21 NZ NZ244420A patent/NZ244420A/xx not_active IP Right Cessation
- 1992-09-22 JP JP4252692A patent/JP2568356B2/ja not_active Expired - Fee Related
- 1992-09-22 RU SU925052552A patent/RU2058312C1/ru active
- 1992-09-22 KR KR1019920017228A patent/KR100254085B1/ko not_active Expired - Fee Related
- 1992-09-22 MX MX9205365A patent/MX9205365A/es unknown
- 1992-09-22 RO RO92-01218A patent/RO109337B1/ro unknown
- 1992-09-23 ZA ZA927279A patent/ZA927279B/xx unknown
- 1992-09-24 TW TW081107550A patent/TW222630B/zh active
-
1995
- 1995-06-13 HU HU95P/P00198P patent/HU211261A9/hu unknown
-
1996
- 1996-10-24 GR GR960402593T patent/GR3021444T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0239445A3 (en) | 1,2,5,6-tetrahydropyridine-3-carboxaldehyde oxime derivatives, process for their preparation, compositions containing them and their use as medicines | |
| GR3021444T3 (en) | Imidazolylmethyl-pyridines | |
| ZA895915B (en) | Disubstituted benzylamines,their preparation process,their use as medicine and their synthesising agents | |
| GR3004652T3 (OSRAM) | ||
| JPS6468356A (en) | Novel 1,2,5,6-tetrahydropyridine-3-carboxaldehydro oxime derivatives, use as drug and composition | |
| JPS6426553A (en) | Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition |